Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | -6.38% |
|
-4.12% | 0.00% |
06-27 | Kindly MD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
06-10 | KindlyMD Partners With Curaleaf for Patient Education on Medical Cannabis Care in Utah | MT |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 2.504 | 3.787 | 3.769 |
EBITDA 1 | 0.0662 | -2.64 | -1.515 |
EBIT 1 | 0.0613 | -2.693 | -1.62 |
Operating Margin | 2.45% | -71.12% | -42.99% |
Earnings before Tax (EBT) 1 | 0.1493 | -2.541 | -1.617 |
Net income 1 | 0.1493 | -2.541 | -1.617 |
Net margin | 5.96% | -67.09% | -42.92% |
EPS | - | -1.565 | -0.3594 |
Free Cash Flow | - | 0.484 | 0.4406 |
FCF margin | - | 12.78% | 11.69% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 5/2/23 | 5/2/23 | 3/12/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 0.02 | 0.26 | 0.14 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | 0.2284 x | -0.0979 x | -0.0948 x |
Free Cash Flow | - | 0.48 | 0.44 |
ROE (net income / shareholders' equity) | - | -777% | -1,187% |
ROA (Net income/ Total Assets) | - | -232% | -94.9% |
Assets 1 | - | 1.093 | 1.704 |
Book Value Per Share | - | 0.0900 | -0.0200 |
Cash Flow per Share | - | 0.0400 | 0.1100 |
Capex 1 | 0.06 | 0.32 | 0.01 |
Capex / Sales | 2.54% | 8.38% | 0.38% |
Announcement Date | 5/2/23 | 5/2/23 | 3/12/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 16.57M | |
+26.83% | 89.91B | |
-26.09% | 73.26B | |
+1.62% | 26.92B | |
-9.85% | 17.27B | |
-0.14% | 16.9B | |
-0.39% | 15.26B | |
+75.62% | 13.51B | |
+83.01% | 13.51B | |
-25.96% | 12.8B |
- Stock Market
- Equities
- KDLY Stock
- Financials Kindly MD, Inc.